Montelukast Prescribing at THE NEW SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
338
Total Quantity
9,681
NHS Cost
£486
vs National Avg
-50.6%
THE NEW SURGERY prescribed 338 items of Montelukast over the last 12 months at a cost of £486 to the NHS. This is 50.6% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
23
Jun 2026
26
Jun 2026
31
Jun 2026
23
Jun 2026
27
Jun 2026
38
Jun 2026
23
Jun 2026
32
Jun 2026
31
Jun 2026
28
Jun 2026
19
Jun 2026
37
Prescribing Details
| Total Items | 338 |
|---|---|
| Total Quantity | 9,681 |
| Total NHS Cost | £486 |
| Presentations | 4 different forms |
| vs National Average | -50.6% |
Montelukast Prescribing Comparison
| This practice | 338 items |
|---|---|
| National average per practice | 685 items |
| Difference | -50.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.